Ken Griffin Ice Cure Medical Ltd. Transaction History
Citadel Advisors LLC
- $550 Billion
- Q2 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Ice Cure Medical Ltd. stock. As of the latest transaction made, Citadel Advisors LLC holds 52,524 shares of ICCM stock, worth $43,069. This represents 0.0% of its overall portfolio holdings.
Number of Shares
52,524Holding current value
$43,069% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding ICCM
# of Institutions
19Shares Held
249KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA40.5KShares$33,1710.0% of portfolio
-
Two Sigma Securities, LLC New York, NY25.3KShares$20,7830.0% of portfolio
-
Gunderson Capital Management Inc.20KShares$16,4000.01% of portfolio
-
Lpl Financial LLC Fort Mill, SC18.9KShares$15,4770.0% of portfolio
-
Hrt Financial LP New York, NY16.8KShares$13,7980.0% of portfolio
About IceCure Medical Ltd.
- Ticker ICCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 36,835,600
- Market Cap $30.2M
- Description
- IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.